Page last updated: 2024-12-06

proligestone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

proligestone: a synthetic progestational steroid; used to suppress ESTRUS [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71906
CHEMBL ID2106696
SCHEMBL ID796537
MeSH IDM0068628

Synonyms (27)

Synonym
proligestone
D08429
23873-85-0
proligestone (inn)
delvosteron [veterinary] (tn)
covinan [veterinary] (tn)
delvosteron
covinan
CHEMBL2106696
proligestona [inn-spanish]
einecs 245-922-6
proligestona
55772lj01v ,
proligestone [inn:ban]
proligestonum
14,17-dihydroxypregn-4-ene-3,20-dione, cyclic acetal with propionaldehyde
proligestonum [inn-latin]
unii-55772lj01v
SCHEMBL796537
proligestone [inn]
proligestone [mart.]
proligestone [mi]
J-015252
(1r,2r,10r,11s,14s,15r)-15-acetyl-17-ethyl-10,14-dimethyl-16,18-dioxapentacyclo[13.3.2.01,14.02,11.05,10]icos-5-en-7-one
Q907070
DTXSID501016687
S12326

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Effects on cortisol persisted for two weeks after MA dosage ceased."( Comparative effects of proligestone and megestrol acetate on basal plasma glucose concentrations and cortisol responses to exogenous adrenocorticotrophic hormone in cats.
Church, DB; Emslie, DR; Middleton, DJ; Watson, AD, 1989
)
0.59
" The cats given MA (n = 7) developed significant suppression of plasma ACTH concentrations and hyperinsulinaemia during treatment and for two to four weeks after MA dosage ceased."( Effects of proligestone and megestrol on plasma adrenocorticotrophic hormone, insulin and insulin-like growth factor-1 concentrations in cats.
Church, DB; Emslie, DR; Middleton, DJ; Tan, K; Watson, AD; Wong, D, 1994
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (46.88)18.7374
1990's10 (31.25)18.2507
2000's6 (18.75)29.6817
2010's1 (3.13)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.68 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index60.75 (26.88)
Search Engine Supply Index1.96 (0.95)

This Compound (42.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.03%)5.53%
Reviews0 (0.00%)6.00%
Case Studies5 (15.15%)4.05%
Observational0 (0.00%)0.25%
Other27 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]